Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 30, 2009
A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in SwedenUlf Persson, Michael Willis, Knut OdegaardJournal of Medical Economics|May 31, 2013
Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM)Michael Willis, Christian Asseburg, Jianming HeDiabetes Research and Clinical Practice|January 15, 2019
Conducting and interpreting results of network meta-analyses in type 2 diabetes mellitus: A review of network meta-analyses that include sodium glucose co-transporter 2 inhibitorsMichael Willis, Christian Asseburg, Cheryl NeslusanDiabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 26, 2019
Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature ReviewMichael Willis, Christian Asseburg, Andreas Nilsson, et al.Applied Health Economics and Health Policy|November 4, 2010
Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in SwedenMichael Willis, Ulf Persson, York Zoellner, et al.Pharmacoeconomics|November 14, 2016
Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)Michael Willis, Pierre Johansen, Andreas Nilsson, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 3, 2011
Chromogranin peptides in brain diseasesMichael Willis, Irmgard Leitner, Kurt A Jellinger, et al.Pharmacoeconomics|May 14, 2020
Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DMMichael Willis, Adam Fridhammar, Jens Gundgaard, et al.Pharmacoeconomics|February 13, 2021
Macrovascular Risk Equations Based on the CANVAS ProgramMichael Willis, Christian Asseburg, April Slee, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 15, 2020
Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial DataMichael Willis, Christian Asseburg, April Slee, et al.Pageof 6